CD274 and sarcoma: A histopathological examination of the biopsy taken at recurrence revealed expression of PD-L1 on sarcoma cells of 10% of the sections, prompting the patient’s care team to initiate treatment with pembrolizumab 2 mg/kg once every 21 days.